- 企业管理与咨询报告
中国医药行业市场研究分析(英文105页)
Table of Contents
IMS MARKET PROGNOSIS .........6
MARKET OVERVIEW AND FORECASTS .........7
MARKET SYNOPSIS ............ 7TOTAL MARKET FORECASTS 2012-2016 ........... 9ANALYSIS OF REBATES AND DISCOUNTS .............. 9SUMMARY OF THE PROGNOSIS .......... 9HOSPITAL SECTOR OVERVIEW ............. 11HOSPITAL SECTOR FORECASTS ........ 13EVENT ANALYSIS ............. 15FORECASTING DATA AND METHODS ............. 20DATA SOURCES ........... 20BASELINE EXTRAPOLATIONS ........... 20HOSPITAL SECTOR BASELINE EXTRAPOLATIONS ........... 21ECONOMIC INDICATORS ........ 22THERAPEUTIC CLASS FORECASTS ........ 23IMS MARKET PROGNOSIS REPORT ...........25BUSINESS ENVIRONMENT ...............26ECONOMIC ENVIRONMENT ......... 26ECONOMIC GROWTH ............. 26INFLATION ......... 26POPULATION, EMPLOYMENT AND INCOME ........... 26FISCAL POLICY ............. 27MONETARY POLICY ................ 27FOREIGN TRADE AND CURRENT ACCOUNT ........... 27EXCHANGE RATE .......... 28POLITICAL ENVIRONMENT .......... 30POLITICAL INSTITUTIONS ............... 30CURRENT GOVERNMENT ......... 3018th PARTY CONGRESS 2012 ........... 31WUKAN VILLAGE PROTEST .............. 32INTERNATIONAL RELATIONS ............ 32
HEALTHCARE ENVIRONMENT ...........33
HEALTHCARE PROVISION ........... 33Market Prognosis Scenario 2012-2016: Healthcare Provision ............. 33HEALTHCARE SYSTEM ............ 34HEALTH STATUS ........... 36HEALTHCARE FINANCING AND EXPENDITURE ............... 38PHARMACEUTICAL EXPENDITURE .............. 38HEALTHCARE POLICY ............. 41DRUG POLICY .............. 42HEALTH INSURANCE .............. 43HOSPITAL SECTOR ................ 45HOSPITAL DRUG PROCUREMENT ............... 48COMMUNITY CARE ........ 50PRESCRIBING AND DISPENSING .......... 52Market Prognosis Scenario 2012-2016: Prescribing and Dispensing ............. 52PRESCRIBING INFLUENCES .............. 52ANTIBIOTIC PRESCRIBING .............. 55ESSENTIAL DRUG LIST ........... 56NATIONAL REIMBURSEMENT DRUG LIST ............. 56PATIENT CO-PAYMENT ........... 58HOSPITAL FORMULARIES ................ 58PRESCRIPTION-ONLY POLICY ........... 58SEPARATION OF PRESCRIBING AND DISPENSING .......... 58PRICING ................ 59Market Prognosis Scenario 2012-2016: Pricing .............. 59PRICING SYSTEM ......... 59PRICING POLICY REFORM ................ 60PRICE MONITORING .............. 62PRICE CUTS ........ 62PRICE TRENDS ............. 63PHARMACOECONOMICS ......... 64DISCOUNTS AND MARGINS ............. 64REGULATORY ENVIRONMENT ............... 66Market Prognosis Scenario 2012-2016: Regulatory Environment ........ 66STATE FOOD AND DRUG ADMINISTRATION ......... 67PRODUCT REGISTRATION ................ 67CLINICAL TRIALS ......... 68GOOD MANUFACTURING PRACTICE ............ 68POST-MARKETING SURVEILLANCE ............. 69MARKETING AND PROMOTION ......... 69COUNTERFEITS ............ 70INTELLECTUAL PROPERTY ................ 70PHARMACEUTICAL BUSINESS ENVIRONMENT .......... 72Market Prognosis Scenario 2012-2016: Pharmaceutical Business Environment ................ 72OPERATING ENVIRONMENT ............. 73INDUSTRY STRUCTURE .......... 74LEADING CORPORATIONS ............... 76LEADING PRODUCTS .............. 77FOREIGN INVESTMENT ........... 77RESEARCH AND DEVELOPMENT ........ 78GENERICS MARKET ................ 79DISTRIBUTION ............. 80RETAIL PHARMACY ................ 81OTC MARKET ............... 82SALES AND MARKETING ......... 83APPENDIX A: GLOSSARY ........85
APPENDIX B: SOURCES AND METHODS .............87
COVERAGE ............. 87MARKET FORECASTS ............. 88MARKET SEGMENTATION FORECASTS ........ 88THERAPEUTIC CLASS FORECASTS ............. 88REGIONAL OVERVIEWS .......... 89FORECASTING METHODOLOGY ............ 90TOTAL MARKET FORECASTING PROCESS ............. 90MARKET SEGMENTATION FORECASTING PROCESS ........ 91THERAPEUTIC CLASS FORECASTING PROCESS .............. 93SOURCES ............... 94PRIMARY AND SECONDARY MARKET RESEARCH ............ 94PHARMACEUTICAL MARKET DATA .............. 94PHARMACEUTICAL MARKET COVERAGE .......... 95EVENT IMPACT CALCULATION .............. 96DEMOGRAPHIC CHANGES ................ 96NEW PRODUCT LAUNCHES ............... 99CALCULATION OF GENERIC COMPETITION ........... 99USEFUL DEFINITIONS .............. 101COMPOUND ANNUAL GROWTH RATE ........ 101CONSTANT PRICE ................ 101LASPEYRES INDEX ............... 101STANDARD UNITS ............... 102GENERIC DEFINITION USING THE IMS MIDAS MARKET SEGMENTATION FEATURE ........ 102GENERIC DEFINITION WITHOUT THE MARKET SEGMENTATION FEATURE ............ 103[报告关键词]： 医药×所属专题： 医药生物下载《中国医药行业市场研究分析(英文105页)》需 25点，包月包季包年会员（点此注册）免费下载。
一、非注册用户快速自助下载两步完成：1 注册（点此），2 购点卡（） 充值（点此）自主下载
二、非注册用户直接付款（点此付款），付款后短信（18121118831或加微信）告知题目或者Email，我们通过邮件发给您。专题跟踪研究报告
企业出海 新质生产力 低空经济 生成式AI 工业互联网 数字藏品 动力电池 ESG 数字化转型 机械零部件 氢能 碳中和 区块链 元宇宙 建筑 矿产 安永 数字货币 新基建 日化 案例分析 毕马威 贝恩咨询 普华永道 波士顿 罗兰贝格 德勤咨询 埃森哲 麦肯锡 电商 金融科技 人工智能 物联网 互联网金融 大数据 3D打印 食品饮料 家电行业 零售连锁 新能源 商业地产 快递行业 机械设备 汽车 核电 电子产业 电力行业 新兴产业 纺织服装 医药生物 广告传媒 金融投资 航空 旅游 酒业 能源 有色金属 通信 石油化工 物流供应链 房地产 可行性报告 PPP 商业计划书 五力分析 并购重组 发展战略 SWOT 产业链 钻石模型 价值链 PEST 人力资源 面板模型 stata 精华推荐 供应链金融 互联网+ 机器人 O2O 教育培训 论文资料查找 写作修改服务 EMBA论文写作 硕士论文 本科论文 论文写作每年为数千个企事业和个人提供专业化服务；量身定制你需要的行业报告的资料和报告
相信我们！企业客户遍及全球，提供政府部门、生产制造企业、物流企业、快消品行业专业化咨询服务；个人客户可以提供各类经济管理资料、商业计划、PPT、MBA/EMBA论文指导等。
点此填写您的需求15+年的经验，值得信赖
可以QQ联系我们：896161733；也可以电话：18121118831
商务服务
可以微信或者电话联系：18121118831商务文档撰写提供商业计划书、投资计划书咨询、撰写和指导
商务咨询业务服务企业、政府和投资者，提供各个产业可行性研究报告撰写和咨询服务
商务咨询业务为企业提供物流园区规划咨询，包括市场调研、可行性、总体战略和运营规划等等
商务PPT制作商业计划书是一份全方位的项目计划，它从企业内部的人员、制度、管理以及企业的产品、营销、市场等各个方面对即将展开的商业项目进行可行性分析（包含论文PPT）。
×
![]()